Co-Chairs

Uttam Dhillon

Chair, Regulatory Defense, Compliance & White-Collar Practice Group
Michael Best & Friedrich LLP
(Former Chief Counsel, U.S. Drug Enforcement Administration)

Dayle Elieson

Principal
Dayle Elieson PLLC
(Former Chief Counsel, U.S. Drug Enforcement Administration)

Keynote Speakers

Eric Triana

Deputy Assistant Administrator
DEA Office of Diversion Control Operations

DEA KEYNOTE ADDRESS

July 13, 2022 10:00 am

Amanda Liskamm

Principal Deputy Director, Consumer Protection Branch
U.S. Department of Justice

DOJ KEYNOTE ADDRESS

July 12, 2022 10:00 am

Dominic Chiapperino, Ph.D.

Director, Controlled Substances Staff
U.S. Food and Drug Administration

FDA KEYNOTE ADDRESS

July 13, 2022 1:30 pm

Government

Scott B. Dahlquist

Trial Attorney, Consumer Protection Branch
U.S. Department of Justice

Dwayne Jeffcoat

DEA Diversion Investigator
U.S. Drug Enforcement Administration

Elliot M. Schachner

Assistant U.S. Attorney
U.S. Attorney’s Office Eastern District of New York

In-House Leadership, In-House Counsel, Consultants, and Law Firms

Michele Buenafe

Partner
Morgan, Lewis & Bockius LLP

Charrai Byrd, PharmD

Pharmacy Operations Manager - Controlled Substances
New York-Presbyterian Hospital

Hunter G. DeKoninck

Practice Group Attorney
Quarles & Brady LLP

Tom Firestone

Partner
Stroock & Stroock & Lavan LLP

Todd A. Harrison

Partner
Venable LLP

Derrelle M. Janey

Managing Partner
The Janey Law Firm PC

Michael Labson

Partner
Covington & Burling LLP

Seth A. Mailhot

Partner
Husch Blackwell LLP

Andrew O’Connor

Partner
Ropes & Gray LLP

Karla L. Palmer

Director
Hyman, Phelps & McNamara PC

Jason Parish

Shareholder
Buchanan Ingersoll & Rooney PC

Joseph Shepherd

Global Senior Director, Controlled Substances Leader
The Janssen Pharmaceutical Companies of Johnson & Johnson

Will Woodlee

Partner
Kleinfeld, Kaplan & Becker LLP